ZERBINI, MARIALUISA
 Distribuzione geografica
Continente #
NA - Nord America 6.212
AS - Asia 5.709
EU - Europa 4.858
AF - Africa 313
SA - Sud America 228
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.328
Nazione #
US - Stati Uniti d'America 6.148
CN - Cina 1.736
VN - Vietnam 1.434
SG - Singapore 1.427
GB - Regno Unito 1.304
DE - Germania 625
IT - Italia 615
UA - Ucraina 582
SE - Svezia 528
HK - Hong Kong 359
FR - Francia 315
IN - India 314
RU - Federazione Russa 281
IE - Irlanda 175
BR - Brasile 166
JP - Giappone 123
ZA - Sudafrica 101
KR - Corea 100
CH - Svizzera 89
EE - Estonia 84
TG - Togo 72
NL - Olanda 52
SC - Seychelles 49
FI - Finlandia 47
CI - Costa d'Avorio 45
BG - Bulgaria 42
CA - Canada 41
BE - Belgio 35
IR - Iran 32
NG - Nigeria 28
AR - Argentina 24
BD - Bangladesh 20
GR - Grecia 20
IQ - Iraq 19
PH - Filippine 17
AT - Austria 16
TH - Thailandia 15
UZ - Uzbekistan 15
ID - Indonesia 13
RO - Romania 12
EC - Ecuador 11
JO - Giordania 11
PK - Pakistan 11
PL - Polonia 11
TW - Taiwan 11
SA - Arabia Saudita 10
TR - Turchia 9
MX - Messico 8
LB - Libano 7
CO - Colombia 6
ES - Italia 6
MY - Malesia 6
PY - Paraguay 6
CL - Cile 5
EG - Egitto 5
AU - Australia 4
AZ - Azerbaigian 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
LT - Lituania 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BM - Bermuda 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TN - Tunisia 2
VE - Venezuela 2
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
ZM - Zambia 1
Totale 17.328
Città #
Southend 1.100
Singapore 905
Ashburn 610
Chandler 540
Fairfield 458
Dong Ket 448
Jacksonville 404
San Jose 353
Hong Kong 342
Hefei 291
Ho Chi Minh City 244
Wilmington 244
Ann Arbor 243
Seattle 242
Princeton 239
Woodbridge 232
Houston 223
Hanoi 196
Beijing 187
Boardman 187
Dublin 171
Cambridge 156
Tokyo 119
Padova 115
Santa Clara 115
Westminster 115
Nanjing 110
Lauterbourg 104
Los Angeles 90
Berlin 85
Seoul 82
Bern 78
New York 78
Buffalo 74
Medford 73
Lomé 72
Milan 71
Council Bluffs 69
Mülheim 69
Saint Petersburg 63
Shenyang 58
Jinan 52
Mahé 47
Abidjan 45
Helsinki 44
Shanghai 44
Sofia 42
Tianjin 42
Changsha 41
Bologna 40
Bengaluru 38
Dallas 38
Guangzhou 37
Redwood City 37
Haiphong 36
Nanchang 36
Brussels 35
Hebei 31
Zhengzhou 31
Florence 28
Abeokuta 27
Da Nang 26
Hangzhou 25
San Diego 25
Verona 25
Bremen 24
Des Moines 23
Frankfurt am Main 22
Jiaxing 22
Phoenix 20
Paris 19
San Francisco 19
Toronto 19
Olalla 18
Taizhou 18
San Venanzo 17
Norwalk 16
Shijiazhuang 15
São Paulo 15
London 14
Ningbo 14
Wuhan 14
Chicago 13
Shenzhen 13
Taiyuan 13
The Dalles 13
Yubileyny 13
Haikou 12
Redondo Beach 12
Turin 12
Amman 11
Biên Hòa 11
Falkenstein 11
Falls Church 11
Kuban 11
Pune 11
Rio de Janeiro 11
Rome 11
Curitiba 10
Mountain View 10
Totale 11.045
Nome #
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 251
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 243
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 227
Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting 211
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 211
Parvovirus in gravidanza: possibili conseguenze della trasmissione verticale 208
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 203
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 202
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 201
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 201
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 199
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 196
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 193
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 192
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 190
Analysis of HPV16 E6*I-II transcripts in cervical samples 190
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 187
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 187
A proteomic approach to the analysis of B19 capsid proteins 187
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 186
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 182
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 181
Analisi della competenza funzionale di cloni genomici di parvovirus B19 181
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 180
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 180
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 179
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 177
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 174
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 174
Recurrent erythema in patients with long-term parvovirus B19 infection 173
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C(HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy 171
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 171
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 166
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 166
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 166
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 166
Parvovirus B19-derived fetal complications following gestational infection. 166
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 163
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 162
Analysis of the functional competence of genomic clones of Parvovirus B19 162
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 161
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 160
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 160
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 159
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 158
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 157
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 157
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 155
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 154
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 154
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 154
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 153
Diagnosi virologica di infezione da papillomavirus umani 151
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 151
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 151
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 151
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 151
Evidence of human bocavirus viremia in healthy blood donors. 151
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 151
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 149
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 148
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 148
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 148
Parvovirus B19 in pregnancy: possible consequence of vertical transmission 146
Human papillomavirus in melanoma: reply from authors 146
Factors predicting the outcome of conservately trated adenocarcinoma in situ of uterine cervix: an analysis of 166 cases 145
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 144
High-throughput type-specific detection of HPV using MassARRAY technology 143
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 142
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 142
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 141
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 141
Implicazioni nella progressione della patologia cervicale 140
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 137
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 134
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 132
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 132
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 132
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 131
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 130
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 129
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 129
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 128
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 128
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 128
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 127
La biologia molecolare nella diagnosi delle infezioni da HPV 126
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 126
B19 parvovirus infections: diagnostic technologies 125
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 125
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 124
Detection of parvovirus B19 IgG: choice of antigens and serological tests 121
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 116
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 114
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 112
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 112
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics 109
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 109
Construction and functional analysis of B19 genomic clones 105
Transduction activity and properties of genomic and subgenomic clones of parvovirus B19 104
Totale 15.792
Categoria #
all - tutte 47.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.109


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021732 0 0 0 0 0 0 0 0 0 0 0 732
2021/20222.085 140 105 142 226 177 107 25 112 62 215 358 416
2022/20232.233 251 328 120 269 159 140 61 124 349 36 225 171
2023/2024807 38 96 40 131 47 161 114 70 19 34 17 40
2024/20251.975 73 333 211 134 278 104 221 52 17 61 52 439
2025/20264.640 337 594 495 420 581 298 333 128 833 338 163 120
Totale 17.616